Insulin-like growth factor receptor I mediates resistance to anti-epidermal growth factor receptor therapy in primary human glioblastoma cells through continued activation of phosphoinositide 3-kinase signaling. - Chakravarti,A.; Loeffler,J.S.; Dyson,N.J. (Cancer Res, 2002)